Hussein Awada

23PUBLICATIONS
75CO-AUTHORS
Predictive and prognostic markersRespiratory diseasesHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Dec 03, 2025
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study.

Carmelo Gurnari, Hideki Makishima, Arda Durmaz

|Jan 29, 2025
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World.

Bruno Fattizzo, Carmelo Gurnari, Sabrina Giammarco

|Jan 04, 2025
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia.

Luca Guarnera, Carmelo Gurnari, Carlos Bravo-Perez

|Oct 04, 2024
Synergistic effect of concurrent high molecular risk mutations and lower JAK2 mutant variant allele frequencies on prognosis in patients with myelofibrosis-insights from a multicenter study.

Yu-Hung Wang, Chao-Hung Wei, Chien-Chin Lin

|May 31, 2024
Impact of Extraosseous Extramedullary Disease on Outcomes of Patients with Relapsed-Refractory Multiple Myeloma receiving Standard-of-Care Chimeric Antigen Receptor T-Cell Therapy.

Danai Dima, Al-Ola Abdallah, James A Davis

|May 11, 2024
Context-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis.

Hussein Awada, Arda Durmaz, Tariq Kewan

Pageof 4

Frequent Collaborators

10 joint publications

Jaroslaw P Maciejewski

10 joint publications

Carmelo Gurnari

9 joint publications

Valeria Visconte

4 joint publications

Faiz Anwer